Documents
Exploring the breadth of impacts arising from MRC supported institutes and major investments (PDF)
If you cannot open or read this document, you can ask for a different format.
Request a different format
Email web@ukri.org, telling us:
- the name of the document
- what format you need
- any assistive technology you use (such as type of screen reader).
Find out about our approach to the accessibility of our website.
Details
This report highlights a selection of recent research impacts from MRC supported institutes and long-established major investments.
Although the research impacts included in this report arose between 2020 and 2023, the underpinning knowledge that contributed to these impacts often spanned decades of discovery science carried out by academic researchers funded by MRC.
As these institutes and major investments do not report impacts from their research to the Research Excellence Framework (REF) assessment, impacts from this part of MRC’s portfolio did not feature in our analysis of MRC-funded non-academic impacts submitted to REF2021 report, published in June 2023.
MRC supports five institutes that together study biological mechanisms and disease process from molecules, through cells to individuals and populations. In addition to these major investments, MRC also provides long-term sustained support for critical UK biomedical research infrastructures.
This report addresses that gap, providing an overview of breadth of impacts arising from MRC-funded research with exemplar case studies from these institutes and major investments.